Hoth Therapeutics Secures Chinese Patent for Revolutionary Cancer Cell Targeting Technology#United_States#New_York#Hoth_Therapeutics#Patent_Technology#Cancer_Cells
Hoth Therapeutics Secures Chinese Patent for Revolutionary Cancer Cell Targeting Technology
Hoth Therapeutics has received a crucial patent in China for its innovative therapeutic platform targeting cancer cells, reinforcing its global presence.
third-news.com
March 31, 2026 at 12:47 PM
Hoth Therapeutics Secures Chinese Patent for Revolutionary Cancer Cell Targeting Technology#United_States#New_York#Hoth_Therapeutics#Patent_Technology#Cancer_Cells
Kanazawa University Unveils New Method for Studying Cancer Cell Flexibility Using Nanotechnology#Japan#Kanazawa_University#Kanazawa#Nanoendoscopy-AFM#Cancer_Cells
Kanazawa University Unveils New Method for Studying Cancer Cell Flexibility Using Nanotechnology
Researchers at Kanazawa University have developed a groundbreaking method to measure the nuclear elasticity of cancer cells, enhancing diagnostic capabilities.
third-news.com
October 28, 2025 at 7:59 AM
Kanazawa University Unveils New Method for Studying Cancer Cell Flexibility Using Nanotechnology#Japan#Kanazawa_University#Kanazawa#Nanoendoscopy-AFM#Cancer_Cells
Just out in #Molecular_Cancer a beautiful journey with Ivana de la Serna and Francois Vallette discussing #cancer_cells #clonal_evolution and #resistance to treatments from 3 different and complementary points of view. Hope you will enjoy read this review as we enjoyed writing it.
rdcu.be/emfur
rdcu.be/emfur
Death-ision: the link between cellular resilience and cancer resistance to treatments
rdcu.be
May 16, 2025 at 1:29 PM
Just out in #Molecular_Cancer a beautiful journey with Ivana de la Serna and Francois Vallette discussing #cancer_cells #clonal_evolution and #resistance to treatments from 3 different and complementary points of view. Hope you will enjoy read this review as we enjoyed writing it.
rdcu.be/emfur
rdcu.be/emfur